(Q81972128)

English

A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis

scientific article published on 16 September 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Lisiane Maria Enriconi dos Anjos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ivanio Alves Pereira

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Eleonora d 'Orsi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Andrea Piette Seaman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Rufus Watson Burlingame

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Edelton Flavio Morato

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

16 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

153-158

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-keratin antibodies in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies in rheumatoid arthritis and their clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of the anti-CCP assay: experiences with 700 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to filaggrin/deiminated fibrin (AFA) are useful for the diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiperinuclear factor and keratin antibodies in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18795390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-008-0999-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18795390%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81972128&oldid=1401781939"